Alvotech's (NASDAQ:ALVO) biggest owners are private equity firms who got richer after stock soared 19% last week [Yahoo! Finance]
Alvotech (ALVO)
Company Research
Source: Yahoo! Finance
63% of the business is held by the top 2 shareholders Using data from analyst forecasts alongside ownership research, one can better assess the future performance of a company A look at the shareholders of Alvotech ( NASDAQ:ALVO ) can tell us which group is most powerful. With 34% stake, private equity firms possess the maximum shares in the company. That is, the group stands to benefit the most if the stock rises (or lose the most if there is a downturn). As a result, private equity firms collectively scored the highest last week as the company hit US$3.6b market cap following a 19% gain in the stock. Let's take a closer look to see what the different types of shareholders can tell us about Alvotech. View our latest analysis for Alvotech What Does The Institutional Ownership Tell Us About Alvotech? Institutional investors commonly compare their own returns to the returns of a commonly followed index. So they generally do consider buying larger companies that are includ
Show less
Read more
Impact Snapshot
Event Time:
ALVO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ALVO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ALVO alerts
High impacting Alvotech news events
Weekly update
A roundup of the hottest topics
ALVO
News
- Alvotech Initiates Confirmatory Patient Study for AVT16, a Proposed Biosimilar to Entyvio® [Yahoo! Finance]Yahoo! Finance
- Alvotech Initiates Confirmatory Patient Study for AVT16, a Proposed Biosimilar to Entyvio®GlobeNewswire
- Alvotech to Participate in the Morgan Stanley 22nd Annual Global Healthcare ConferenceGlobeNewswire
- Alvotech Second Quarter 2024 Earnings: EPS: US$0.25 (vs US$0.83 in 2Q 2023) [Yahoo! Finance]Yahoo! Finance
- Alvotech (ALVO) Q2 2024 Earnings Call Transcript [Seeking Alpha]Seeking Alpha
ALVO
Earnings
- 5/21/24 - Miss
ALVO
Sec Filings
- 8/30/24 - Form EFFECT
- 8/29/24 - Form 424B3
- 8/21/24 - Form F-3
- ALVO's page on the SEC website